TCL Archive Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer June 24, 2005
TCL Archive In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked May 15, 1981
TCL Archive The White House: President’s Proclamation For Breast Cancer Awareness Month October 9, 1998
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
